Bajaj HealthCare

579.00
+17.00
(3.02%)
Market Cap
1,828.67 Cr
EPS
-30.36
PE Ratio
40.73
Dividend Yield
0.16 %
Industry
Healthcare
52 Week High
745.00
52 Week Low
263.30
PB Ratio
3.99
Debt to Equity
1.16
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Bajaj Healthcare Appoints Rohan Parekh as Chief Financial Officer4 days ago
Bajaj Healthcare has approved the appointment of Rohan Parekh as the company's new Chief Financial Officer. This decision represents a significant change in the company's financial leadership.
positive
Bajaj Healthcare Acquires Genrx Pharmvtm and Considers Bonus Share Issue7 days ago
Bajaj Healthcare has expanded its manufacturing capabilities by acquiring Genrx Pharmvtm for ₹10.85 crore in cash, gaining 100% control of the target entity. The company's board is scheduled to meet on April 16 to consider a proposal for issuing bonus shares.
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,687.55
#1 4,04,899.77
33.61
#1 49,887.20
12.06
#1 9,648
13.77
47.60
5,589.30
1,48,378.35
69.15
8,184.00
0.89
1,600
#1 64.53
47.92
1,463.05
1,18,158.10
22.92
26,520.70
14.17
4,155
47.38
50.89
3,129.00
1,05,899.58
56.83
10,785.70
11.59
1,656
13.54
45.29
2,350.50
96,976.58
46.77
10,615.60
19.57
1,942
-16.38
48.68
1,109.50
92,582.82
#1 17.01
28,905.40
12.36
5,578
1.69
40.66
1,969.25
89,904.33
30.58
20,141.50
#1 19.94
1,936
38.82
46.62
868.85
87,426.64
18.74
19,831.50
13.82
3,831
29.92
44.56
29,641.10
62,985.27
46.40
6,097.20
10.80
1,201
16.01
48.36
1,082.45
62,868.87
17.41
29,559.20
17.55
3,169
-10.04
41.61
Growth Rate
Revenue Growth
-25.53 %
Net Income Growth
-122.52 %
Cash Flow Change
515.91 %
ROE
-129.80 %
ROCE
-82.65 %
EBITDA Margin (Avg.)
0.97 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
218
223
233
329
371
417
664
681
647
482
538
Expenses
190
193
200
288
328
362
521
561
534
397
484
EBITDA
29
30
33
41
44
55
143
120
113
85
54
Operating Profit %
13 %
13 %
13 %
12 %
12 %
12 %
21 %
17 %
17 %
16 %
8 %
Depreciation
9
9
11
11
11
12
16
18
17
28
28
Interest
8
8
8
8
8
6
8
13
18
30
28
Profit Before Tax
12
14
14
23
24
36
119
90
78
-17
-2
Tax
5
5
6
8
8
11
36
18
15
-2
0
Net Profit
8
8
8
15
16
25
83
71
64
-14
-2
EPS in ₹
11.13
12.15
11.37
22.01
11.82
18.29
30.11
25.87
15.59
-30.36
-1.20

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
189
209
219
268
283
343
526
721
898
765
Fixed Assets
109
130
128
127
156
162
208
270
366
253
Current Assets
79
78
91
140
124
168
258
398
500
405
Capital Work in Progress
1
2
0
2
1
5
57
52
22
7
Investments
0
0
0
0
0
5
0
0
0
0
Other Assets
79
78
91
140
126
170
261
399
510
506
Total Liabilities
189
209
219
268
283
343
526
721
898
765
Current Liabilities
85
88
93
131
111
138
183
322
434
402
Non Current Liabilities
22
32
28
23
19
27
85
71
96
85
Total Equity
82
89
99
114
153
178
258
329
368
278
Reserve & Surplus
78
82
92
107
146
164
245
315
354
265
Share Capital
4
7
7
7
7
14
14
14
14
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-0
1
7
-0
-4
10
-12
16
-16
Investing Activities
-17
-31
-8
-12
-13
-28
-109
-75
-93
-11
Operating Activities
28
25
22
17
25
21
44
1
-22
92
Financing Activities
-11
5
-13
3
-13
3
76
62
131
-97

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Nov 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.26 %
67.30 %
67.30 %
67.42 %
67.49 %
67.49 %
67.69 %
67.73 %
67.73 %
67.73 %
59.19 %
59.19 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.66 %
0.74 %
0.53 %
0.01 %
1.07 %
1.01 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.34 %
0.34 %
0.34 %
0.44 %
0.48 %
0.44 %
0.00 %
1.97 %
2.36 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
9.79 %
12.67 %
13.95 %
13.95 %
14.85 %
16.53 %
16.71 %
16.50 %
16.67 %
16.45 %
16.80 %
18.44 %
19.45 %
19.91 %
20.17 %
25.52 %
26.94 %
Others
22.94 %
20.06 %
18.79 %
18.79 %
17.89 %
16.21 %
15.99 %
16.21 %
15.57 %
15.73 %
15.37 %
12.78 %
11.61 %
11.39 %
12.09 %
12.26 %
10.50 %
No of Share Holders
7,236
13,283
26,707
31,462
32,309
30,723
30,909
29,769
26,930
26,037
27,322
28,008
29,626
32,712
32,397
31,993
32,672

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 2.75 1.5 1 1 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.81 0.52 0.34 0.15 0.00

Corporate Action

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20183 days ago
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 20154 days ago
Board Meeting Outcome for Outcome Of The Board Meeting4 days ago
Announcements Under Regulation 30 Of SEBI (LODR) Regulations 20157 days ago
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 20159 days ago
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 02, 2025
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Apr 02, 2025
Closure of Trading WindowMar 25, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 04, 2025
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011Feb 25, 2025
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011Feb 25, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 11, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 11, 2025
Compliances- Statement Of DeviationFeb 11, 2025
Integrated Filing (Financial)Feb 11, 2025
Results-Financial Results For The Quarter & Nine Months Ended 31St December 2024Feb 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On 11Th February 2025Feb 11, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 07, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 07, 2025
Disclosures under Reg. 29(1) & 29 (2) of SEBI (SAST) Regulations 2011Feb 07, 2025
Board Meeting Intimation for Consideration Of Financial ResultsFeb 05, 2025
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerJan 31, 2025
Announcement Under Regulation 30 Of SEBI LODR 2015Jan 30, 2025
Announcement Under Regulation 30 Of SEBI LODR 2015Jan 30, 2025
Announcement Under Regulation 30 Of LODR RegulationsJan 16, 2025
Change Of Name Of RTAJan 03, 2025
Closure of Trading WindowDec 27, 2024
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Dec 23, 2024
Company Entering Into A CDMO Contract With UK/ EU BasedCompaniesDec 09, 2024
Approval From Therapeutic Goods Administration (TGA), AustraliaDec 06, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Investor ReleaseNov 14, 2024
Statement Of Deviation(S) Or Variation(S) Under Reg. 32Nov 14, 2024
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 14, 2024
Results For 30Th September, 2024Nov 14, 2024
Board Meeting Outcome for Outcome Of Board MeetingNov 14, 2024
Board Meeting Intimation for Board Meeting To Be Held On 14Th November, 2024.Nov 11, 2024
Announcement Under Regulation 30 Of LODR RegulationsOct 29, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportOct 01, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2024
Closure of Trading WindowSep 26, 2024
Company Entering Into A Development And Supply Agreement For An Active Pharmaceutical Ingredient (API) With A European EntitySep 23, 2024
Board Meeting Outcome for Outcome Of The Board Meeting Held On 19Th September, 2024Sep 19, 2024
Board Meeting Intimation for Meeting To Be Held On 19Th September, 2024Sep 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 07, 2024
Book Closure For AGMSep 07, 2024
Record DateSep 07, 2024
Business Responsibility and Sustainability Reporting (BRSR)Sep 06, 2024

Technical Indicators

RSI(14)
Neutral
38.47
ATR(14)
Less Volatile
44.95
STOCH(9,6)
Neutral
23.54
STOCH RSI(14)
Oversold
8.97
MACD(12,26)
Bearish
-15.52
ADX(14)
Weak Trend
20.78
UO(9)
Bearish
40.29
ROC(12)
Downtrend And Accelerating
-16.15
WillR(14)
Neutral
-68.61